Condition
Acute Biphenotypic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Acute Biphenotypic Leukemia clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Acute Biphenotypic Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining venetoclax with chemotherapy for treating acute myeloid leukemia | Phase 1/2 | Seattle, Washington | Recruiting | Mar 15, 2021 |
| Using enasidenib and azacitidine to treat patients with recurrent or refractory acute myeloid leukemia and IDH2 gene mutation | Phase 2 | Houston, Texas | Recruiting | Sep 25, 2018 |
| HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant | Phase 1 | Seattle, Washington | Recruiting | Oct 31, 2017 |
| Personalized NK cell therapy after umbilical cord blood transplant for leukemia | Phase 2 | Houston, Texas | Recruiting | Apr 5, 2016 |
| Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers | Phase 2 | Houston, Texas | Recruiting | Apr 16, 2014 |
All recruiting trials (5)
-
Combining venetoclax with chemotherapy for treating acute myeloid leukemia
This study is testing if combining a drug called venetoclax with a specific chemotherapy can help people with acute myeloid leukemia and high-grade myeloid neoplasms feel better and fight their cancer more effectively.
-
Using enasidenib and azacitidine to treat patients with recurrent or refractory acute myeloid leukemia and IDH2 gene mutation
This study is testing if a combination of two medications, enasidenib and azacitidine, can help people with recurrent or hard-to-treat acute myeloid leukemia that has an IDH2 gene mutation.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
-
Personalized NK cell therapy after umbilical cord blood transplant for leukemia
This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.
-
Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers
This study is testing a new combination of four medications to see if it helps people with certain types of blood cancers feel better and live longer.
Related topics
Quick answers
How many Acute Biphenotypic Leukemia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.